This finding suggests a possible relationship between the circulating inflammatory marker CRP and metabolic alterations related to MetS, as has been suggested in subjects exhibiting MetS in the general population41, and furthermore, CRP has been identified as a predictor of future sequelae of MetS, such as atherosclerotic cardiovascular disease42. The gene discussed is CRP; the disease is metabolic syndrome.